Dental Restorations Effect on Oxidative Status of the Gingival Crevicular Fluid
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03522532 |
|
Recruitment Status :
Completed
First Posted : May 11, 2018
Last Update Posted : May 11, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pharmacological Action | Procedure: Amalgam placement Procedure: Tetric EvoCeram placement Procedure: Beautifil placement Procedure: Zinc phosphate cement placement Procedure: Zinc polycarboxylate cement placement Procedure: Glass ionomer cement placement | Not Applicable |
Six DMs were tested by investigators, each sealed in one session: amalgam (Amg), zinc phosphate cement (ZnPhC), zinc polycarboxylate cement (ZnPoC), glass ionomer cement (GIC) and composites, Tetric EvoCeram (TEC) and Beautifil (BF).
The study included 88 dental outpatients. Oxidative stress parameters, including malondialdehyde (MDA), glutathione (GSH) and total superoxide dismutase (tSOD) activity were measured in GCF, before (day 0) and after treatment (7th and 30th day).
Antagonistically positioned healthy teeth were used as a control.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 88 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | According to Black's Classification Criteria, patients were classified into four groups (K2 - K5). The number of patients within those groups were as follows: K2 (n=58), K3 (n=10), K4 (n=6) and K5 (n=14). Six different DMs were used in this study. The type of DM to be used for each patient was determined in relation to the dental lesion degree. DM placement was performed in one session and only one type was used per patient. Accordingly, 6 groups (arms) of dental patients (Amg, ZnPhC, ZnPoC, GIC, TEC and BF) were formed. Parameters of OS (MDA, GSH and tSOD) were measured in the GCF of the patients both before (day 0) and after treatment (on the 7th and 30th day). |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Redox Interactions Between Dental Restorations and Gingival Crevicular Fluid |
| Actual Study Start Date : | October 2016 |
| Actual Primary Completion Date : | September 2017 |
| Actual Study Completion Date : | November 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Amalgam (Amg)
Amalgam was sealed in 8-K2 patients and 6-K2 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
|
Procedure: Amalgam placement
Before the Amg was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment. |
|
Experimental: Tetric EvoCeram (TEC)
Tetric EvoCeram was sealed in 12-K2 patients and 5-K5 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
|
Procedure: Tetric EvoCeram placement
Before the TEC was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment. |
|
Experimental: Beautifil (BF)
Beautifil was sealed in 15-K2 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
|
Procedure: Beautifil placement
Before the BF was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment. |
|
Experimental: Zinc phosphate cement (ZPhC)
Zinc phosphate cement was sealed in 7-K2 patients, 4-K3 patients, 1-K4 patients and 2-K5 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment. |
Procedure: Zinc phosphate cement placement
Before the ZPhC was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment. |
|
Experimental: Zinc polycarboxylate cement (ZPoC)
Zinc polycarboxylate cement was sealed in 5-K2 patients, 4-K3 patients and 5-K4 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment. |
Procedure: Zinc polycarboxylate cement placement
Before the ZPoC was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment. |
|
Experimental: Glass ionomer cement (GIC)
Glass ionomer cement was sealed in 11-K2 patients, 2-K3 patients and 1-K5 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment. |
Procedure: Glass ionomer cement placement
Before the GIC was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment. |
- Changes in the levels of MDA in dental patients GCF after the applied treatments [ Time Frame: 0th, 7th and 30th days. ]The concentration of MDA in GCF was measured before (0 day) and twice after the applied treatments (7th and 30th days). GCF was taken via the intracervical absorption technique. Control GCF (from mirror-positioned health teeth) was taken once before the treatment.
- Changes in the levels of GSH in dental patients GCF after the applied treatments [ Time Frame: 0th, 7th and 30th days. ]Concentration of GSH in GCF was measured before (0 day) and twice after the applied treatments (7th and 30th days). GCF was taken via the intracervical absorption technique. Control GCF (from mirror-positioned health teeth) was taken once before the treatment.
- Changes in tSOD activity in dental patients GCF after the applied treatments [ Time Frame: 0th, 7th and 30th days. ]Activity of tSOD was measured before (0 day) and twice after the applied treatments (7th and 30th days). GCF was taken via the intracervical absorption technique. Control GCF (from mirror-positioned health teeth) was taken once before the treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Criteria related to the condition of teeth:
- Presence of proximal caries on anterior and posterior teeth
- Existence of the antagonistic tooth ("mirror"-positioned healthy tooth) to be used as control
- An absence of fresh post-extraction or traumatic wounds in the restoration area or in the area of restored surfaces
- An absence of infection in the area of restored surfaces
Other influencing criteria:
- Absence of bone-associated diseases or treatments
- Satisfactory oral hygiene
- Patients exhibiting good compliance
Exclusion Criteria:
Criteria related to the condition of teeth:
- Endodontic and/or periodontal infections in the area of the cervical filling
- Presence of periodontopathy
- Prominent periodontal pockets
- Subgingival carries
- Prominent fillings outside the cavity
Other influencing criteria:
- Patients on radiation or immunosuppressive therapy
- Presence of bone-associated diseases and malignant diseases
- Patients using drugs/alcohol/cigarettes (> 20 cigarettes per day)
- Bad oral hygiene
- Patients exhibiting poor compliance
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03522532
| Serbia | |
| Military Medical Academy | |
| Belgrade, Serbia, 11000 | |
| Principal Investigator: | Mirjana M Djukic, PhD, Pharm. | University of Belgrade | |
| Study Director: | Danilo V Vojvodic | Military Medical Academy, Belgrade |
| Responsible Party: | Ervin Taso, Principal Investigator, Military Medical Academy, Belgrade, Serbia |
| ClinicalTrials.gov Identifier: | NCT03522532 |
| Other Study ID Numbers: |
VMA/10-12/A.1 |
| First Posted: | May 11, 2018 Key Record Dates |
| Last Update Posted: | May 11, 2018 |
| Last Verified: | April 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
|
dental restorations gingival crevicular fluid glutathione lipid peroxidation superoxide dismutase |
|
Zinc Trace Elements Micronutrients Physiological Effects of Drugs |

